Global Quetiapine Market Growth 2022-2028

Publisher Name :
Date: 11-Feb-2022
No. of pages: 108

As the global economy mends, the 2021 growth of Quetiapine will have significant change from previous year. According to our (LP Information) latest study, the global Quetiapine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Quetiapine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Quetiapine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Quetiapine market, reaching US$ million by the year 2028. As for the Europe Quetiapine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Quetiapine players cover AstraZeneca, Intas, TAPI, and Accord, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Quetiapine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

- Immediate Release Tablets

- Extended Release Tablets

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

- Adult

- Old Man

- Children And Adolescents

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

- AstraZeneca

- Intas

- TAPI

- Accord

- Hexal

- Dr.Reddy's

- Lupin

- Sun Pharmaceutical

- Hunan Dongting Pharm

- SuZhou NO.4 Phamaceutical Factory

- Fuan Pharmaceutical

- Zhejiang Supor Pharmaceuticals

- Zhejiang Huahai Pharmaceutical

- Hunan Dongting Pharmaceutical

Global Quetiapine Market Growth 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Quetiapine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Quetiapine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Quetiapine by Country/Region, 2017, 2022 & 2028
2.2 Quetiapine Segment by Type
2.2.1 Immediate Release Tablets
2.2.2 Extended Release Tablets
2.3 Quetiapine Sales by Type
2.3.1 Global Quetiapine Sales Market Share by Type (2017-2022)
2.3.2 Global Quetiapine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Quetiapine Sale Price by Type (2017-2022)
2.4 Quetiapine Segment by Application
2.4.1 Adult
2.4.2 Old Man
2.4.3 Children And Adolescents
2.5 Quetiapine Sales by Application
2.5.1 Global Quetiapine Sale Market Share by Application (2017-2022)
2.5.2 Global Quetiapine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Quetiapine Sale Price by Application (2017-2022)
3 Global Quetiapine by Company
3.1 Global Quetiapine Breakdown Data by Company
3.1.1 Global Quetiapine Annual Sales by Company (2020-2022)
3.1.2 Global Quetiapine Sales Market Share by Company (2020-2022)
3.2 Global Quetiapine Annual Revenue by Company (2020-2022)
3.2.1 Global Quetiapine Revenue by Company (2020-2022)
3.2.2 Global Quetiapine Revenue Market Share by Company (2020-2022)
3.3 Global Quetiapine Sale Price by Company
3.4 Key Manufacturers Quetiapine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Quetiapine Product Location Distribution
3.4.2 Players Quetiapine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Quetiapine by Geographic Region
4.1 World Historic Quetiapine Market Size by Geographic Region (2017-2022)
4.1.1 Global Quetiapine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Quetiapine Annual Revenue by Geographic Region
4.2 World Historic Quetiapine Market Size by Country/Region (2017-2022)
4.2.1 Global Quetiapine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Quetiapine Annual Revenue by Country/Region
4.3 Americas Quetiapine Sales Growth
4.4 APAC Quetiapine Sales Growth
4.5 Europe Quetiapine Sales Growth
4.6 Middle East & Africa Quetiapine Sales Growth
5 Americas
5.1 Americas Quetiapine Sales by Country
5.1.1 Americas Quetiapine Sales by Country (2017-2022)
5.1.2 Americas Quetiapine Revenue by Country (2017-2022)
5.2 Americas Quetiapine Sales by Type
5.3 Americas Quetiapine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Quetiapine Sales by Region
6.1.1 APAC Quetiapine Sales by Region (2017-2022)
6.1.2 APAC Quetiapine Revenue by Region (2017-2022)
6.2 APAC Quetiapine Sales by Type
6.3 APAC Quetiapine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Quetiapine by Country
7.1.1 Europe Quetiapine Sales by Country (2017-2022)
7.1.2 Europe Quetiapine Revenue by Country (2017-2022)
7.2 Europe Quetiapine Sales by Type
7.3 Europe Quetiapine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Quetiapine by Country
8.1.1 Middle East & Africa Quetiapine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Quetiapine Revenue by Country (2017-2022)
8.2 Middle East & Africa Quetiapine Sales by Type
8.3 Middle East & Africa Quetiapine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Quetiapine
10.3 Manufacturing Process Analysis of Quetiapine
10.4 Industry Chain Structure of Quetiapine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Quetiapine Distributors
11.3 Quetiapine Customer
12 World Forecast Review for Quetiapine by Geographic Region
12.1 Global Quetiapine Market Size Forecast by Region
12.1.1 Global Quetiapine Forecast by Region (2023-2028)
12.1.2 Global Quetiapine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Quetiapine Forecast by Type
12.7 Global Quetiapine Forecast by Application
13 Key Players Analysis
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Quetiapine Product Offered
13.1.3 AstraZeneca Quetiapine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Intas
13.2.1 Intas Company Information
13.2.2 Intas Quetiapine Product Offered
13.2.3 Intas Quetiapine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Intas Main Business Overview
13.2.5 Intas Latest Developments
13.3 TAPI
13.3.1 TAPI Company Information
13.3.2 TAPI Quetiapine Product Offered
13.3.3 TAPI Quetiapine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 TAPI Main Business Overview
13.3.5 TAPI Latest Developments
13.4 Accord
13.4.1 Accord Company Information
13.4.2 Accord Quetiapine Product Offered
13.4.3 Accord Quetiapine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Accord Main Business Overview
13.4.5 Accord Latest Developments
13.5 Hexal
13.5.1 Hexal Company Information
13.5.2 Hexal Quetiapine Product Offered
13.5.3 Hexal Quetiapine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Hexal Main Business Overview
13.5.5 Hexal Latest Developments
13.6 Dr.Reddy's
13.6.1 Dr.Reddy's Company Information
13.6.2 Dr.Reddy's Quetiapine Product Offered
13.6.3 Dr.Reddy's Quetiapine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Dr.Reddy's Main Business Overview
13.6.5 Dr.Reddy's Latest Developments
13.7 Lupin
13.7.1 Lupin Company Information
13.7.2 Lupin Quetiapine Product Offered
13.7.3 Lupin Quetiapine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Lupin Main Business Overview
13.7.5 Lupin Latest Developments
13.8 Sun Pharmaceutical
13.8.1 Sun Pharmaceutical Company Information
13.8.2 Sun Pharmaceutical Quetiapine Product Offered
13.8.3 Sun Pharmaceutical Quetiapine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Sun Pharmaceutical Main Business Overview
13.8.5 Sun Pharmaceutical Latest Developments
13.9 Hunan Dongting Pharm
13.9.1 Hunan Dongting Pharm Company Information
13.9.2 Hunan Dongting Pharm Quetiapine Product Offered
13.9.3 Hunan Dongting Pharm Quetiapine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Hunan Dongting Pharm Main Business Overview
13.9.5 Hunan Dongting Pharm Latest Developments
13.10 SuZhou NO.4 Phamaceutical Factory
13.10.1 SuZhou NO.4 Phamaceutical Factory Company Information
13.10.2 SuZhou NO.4 Phamaceutical Factory Quetiapine Product Offered
13.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 SuZhou NO.4 Phamaceutical Factory Main Business Overview
13.10.5 SuZhou NO.4 Phamaceutical Factory Latest Developments
13.11 Fuan Pharmaceutical
13.11.1 Fuan Pharmaceutical Company Information
13.11.2 Fuan Pharmaceutical Quetiapine Product Offered
13.11.3 Fuan Pharmaceutical Quetiapine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Fuan Pharmaceutical Main Business Overview
13.11.5 Fuan Pharmaceutical Latest Developments
13.12 Zhejiang Supor Pharmaceuticals
13.12.1 Zhejiang Supor Pharmaceuticals Company Information
13.12.2 Zhejiang Supor Pharmaceuticals Quetiapine Product Offered
13.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Zhejiang Supor Pharmaceuticals Main Business Overview
13.12.5 Zhejiang Supor Pharmaceuticals Latest Developments
13.13 Zhejiang Huahai Pharmaceutical
13.13.1 Zhejiang Huahai Pharmaceutical Company Information
13.13.2 Zhejiang Huahai Pharmaceutical Quetiapine Product Offered
13.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Zhejiang Huahai Pharmaceutical Main Business Overview
13.13.5 Zhejiang Huahai Pharmaceutical Latest Developments
13.14 Hunan Dongting Pharmaceutical
13.14.1 Hunan Dongting Pharmaceutical Company Information
13.14.2 Hunan Dongting Pharmaceutical Quetiapine Product Offered
13.14.3 Hunan Dongting Pharmaceutical Quetiapine Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Hunan Dongting Pharmaceutical Main Business Overview
13.14.5 Hunan Dongting Pharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Quetiapine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Quetiapine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Immediate Release Tablets
Table 4. Major Players of Extended Release Tablets
Table 5. Global Quetiapine Sales by Type (2017-2022) & (K Pcs)
Table 6. Global Quetiapine Sales Market Share by Type (2017-2022)
Table 7. Global Quetiapine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Quetiapine Revenue Market Share by Type (2017-2022)
Table 9. Global Quetiapine Sale Price by Type (2017-2022) & (US$/Pcs)
Table 10. Global Quetiapine Sales by Application (2017-2022) & (K Pcs)
Table 11. Global Quetiapine Sales Market Share by Application (2017-2022)
Table 12. Global Quetiapine Revenue by Application (2017-2022)
Table 13. Global Quetiapine Revenue Market Share by Application (2017-2022)
Table 14. Global Quetiapine Sale Price by Application (2017-2022) & (US$/Pcs)
Table 15. Global Quetiapine Sales by Company (2020-2022) & (K Pcs)
Table 16. Global Quetiapine Sales Market Share by Company (2020-2022)
Table 17. Global Quetiapine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Quetiapine Revenue Market Share by Company (2020-2022)
Table 19. Global Quetiapine Sale Price by Company (2020-2022) & (US$/Pcs)
Table 20. Key Manufacturers Quetiapine Producing Area Distribution and Sales Area
Table 21. Players Quetiapine Products Offered
Table 22. Quetiapine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Quetiapine Sales by Geographic Region (2017-2022) & (K Pcs)
Table 26. Global Quetiapine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Quetiapine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Quetiapine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Quetiapine Sales by Country/Region (2017-2022) & (K Pcs)
Table 30. Global Quetiapine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Quetiapine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Quetiapine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Quetiapine Sales by Country (2017-2022) & (K Pcs)
Table 34. Americas Quetiapine Sales Market Share by Country (2017-2022)
Table 35. Americas Quetiapine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Quetiapine Revenue Market Share by Country (2017-2022)
Table 37. Americas Quetiapine Sales by Type (2017-2022) & (K Pcs)
Table 38. Americas Quetiapine Sales Market Share by Type (2017-2022)
Table 39. Americas Quetiapine Sales by Application (2017-2022) & (K Pcs)
Table 40. Americas Quetiapine Sales Market Share by Application (2017-2022)
Table 41. APAC Quetiapine Sales by Region (2017-2022) & (K Pcs)
Table 42. APAC Quetiapine Sales Market Share by Region (2017-2022)
Table 43. APAC Quetiapine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Quetiapine Revenue Market Share by Region (2017-2022)
Table 45. APAC Quetiapine Sales by Type (2017-2022) & (K Pcs)
Table 46. APAC Quetiapine Sales Market Share by Type (2017-2022)
Table 47. APAC Quetiapine Sales by Application (2017-2022) & (K Pcs)
Table 48. APAC Quetiapine Sales Market Share by Application (2017-2022)
Table 49. Europe Quetiapine Sales by Country (2017-2022) & (K Pcs)
Table 50. Europe Quetiapine Sales Market Share by Country (2017-2022)
Table 51. Europe Quetiapine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Quetiapine Revenue Market Share by Country (2017-2022)
Table 53. Europe Quetiapine Sales by Type (2017-2022) & (K Pcs)
Table 54. Europe Quetiapine Sales Market Share by Type (2017-2022)
Table 55. Europe Quetiapine Sales by Application (2017-2022) & (K Pcs)
Table 56. Europe Quetiapine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Quetiapine Sales by Country (2017-2022) & (K Pcs)
Table 58. Middle East & Africa Quetiapine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Quetiapine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Quetiapine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Quetiapine Sales by Type (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Quetiapine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Quetiapine Sales by Application (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Quetiapine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Quetiapine
Table 66. Key Market Challenges & Risks of Quetiapine
Table 67. Key Industry Trends of Quetiapine
Table 68. Quetiapine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Quetiapine Distributors List
Table 71. Quetiapine Customer List
Table 72. Global Quetiapine Sales Forecast by Region (2023-2028) & (K Pcs)
Table 73. Global Quetiapine Sales Market Forecast by Region
Table 74. Global Quetiapine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Quetiapine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Quetiapine Sales Forecast by Country (2023-2028) & (K Pcs)
Table 77. Americas Quetiapine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Quetiapine Sales Forecast by Region (2023-2028) & (K Pcs)
Table 79. APAC Quetiapine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Quetiapine Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Europe Quetiapine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Quetiapine Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Middle East & Africa Quetiapine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Quetiapine Sales Forecast by Type (2023-2028) & (K Pcs)
Table 85. Global Quetiapine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Quetiapine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Quetiapine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Quetiapine Sales Forecast by Application (2023-2028) & (K Pcs)
Table 89. Global Quetiapine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Quetiapine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Quetiapine Revenue Market Share Forecast by Application (2023-2028)
Table 92. AstraZeneca Basic Information, Quetiapine Manufacturing Base, Sales Area and Its Competitors
Table 93. AstraZeneca Quetiapine Product Offered
Table 94. AstraZeneca Quetiapine Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 95. AstraZeneca Main Business
Table 96. AstraZeneca Latest Developments
Table 97. Intas Basic Information, Quetiapine Manufacturing Base, Sales Area and Its Competitors
Table 98. Intas Quetiapine Product Offered
Table 99. Intas Quetiapine Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 100. Intas Main Business
Table 101. Intas Latest Developments
Table 102. TAPI Basic Information, Quetiapine Manufacturing Base, Sales Area and Its Competitors
Table 103. TAPI Quetiapine Product Offered
Table 104. TAPI Quetiapine Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 105. TAPI Main Business
Table 106. TAPI Latest Developments
Table 107. Accord Basic Information, Quetiapine Manufacturing Base, Sales Area and Its Competitors
Table 108. Accord Quetiapine Product Offered
Table 109. Accord Quetiapine Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 110. Accord Main Business
Table 111. Accord Latest Developments
Table 112. Hexal Basic Information, Quetiapine Manufacturing Base, Sales Area and Its Competitors
Table 113. Hexal Quetiapine Product Offered
Table 114. Hexal Quetiapine Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 115. Hexal Main Business
Table 116. Hexal Latest Developments
Table 117. Dr.Reddy's Basic Information, Quetiapine Manufacturing Base, Sales Area and Its Competitors
Table 118. Dr.Reddy's Quetiapine Product Offered
Table 119. Dr.Reddy's Quetiapine Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 120. Dr.Reddy's Main Business
Table 121. Dr.Reddy's Latest Developments
Table 122. Lupin Basic Information, Quetiapine Manufacturing Base, Sales Area and Its Competitors
Table 123. Lupin Quetiapine Product Offered
Table 124. Lupin Quetiapine Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 125. Lupin Main Business
Table 126. Lupin Latest Developments
Table 127. Sun Pharmaceutical Basic Information, Quetiapine Manufacturing Base, Sales Area and Its Competitors
Table 128. Sun Pharmaceutical Quetiapine Product Offered
Table 129. Sun Pharmaceutical Quetiapine Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 130. Sun Pharmaceutical Main Business
Table 131. Sun Pharmaceutical Latest Developments
Table 132. Hunan Dongting Pharm Basic Information, Quetiapine Manufacturing Base, Sales Area and Its Competitors
Table 133. Hunan Dongting Pharm Quetiapine Product Offered
Table 134. Hunan Dongting Pharm Quetiapine Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 135. Hunan Dongting Pharm Main Business
Table 136. Hunan Dongting Pharm Latest Developments
Table 137. SuZhou NO.4 Phamaceutical Factory Basic Information, Quetiapine Manufacturing Base, Sales Area and Its Competitors
Table 138. SuZhou NO.4 Phamaceutical Factory Quetiapine Product Offered
Table 139. SuZhou NO.4 Phamaceutical Factory Quetiapine Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 140. SuZhou NO.4 Phamaceutical Factory Main Business
Table 141. SuZhou NO.4 Phamaceutical Factory Latest Developments
Table 142. Fuan Pharmaceutical Basic Information, Quetiapine Manufacturing Base, Sales Area and Its Competitors
Table 143. Fuan Pharmaceutical Quetiapine Product Offered
Table 144. Fuan Pharmaceutical Quetiapine Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 145. Fuan Pharmaceutical Main Business
Table 146. Fuan Pharmaceutical Latest Developments
Table 147. Zhejiang Supor Pharmaceuticals Basic Information, Quetiapine Manufacturing Base, Sales Area and Its Competitors
Table 148. Zhejiang Supor Pharmaceuticals Quetiapine Product Offered
Table 149. Zhejiang Supor Pharmaceuticals Quetiapine Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 150. Zhejiang Supor Pharmaceuticals Main Business
Table 151. Zhejiang Supor Pharmaceuticals Latest Developments
Table 152. Zhejiang Huahai Pharmaceutical Basic Information, Quetiapine Manufacturing Base, Sales Area and Its Competitors
Table 153. Zhejiang Huahai Pharmaceutical Quetiapine Product Offered
Table 154. Zhejiang Huahai Pharmaceutical Quetiapine Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 155. Zhejiang Huahai Pharmaceutical Main Business
Table 156. Zhejiang Huahai Pharmaceutical Latest Developments
Table 157. Hunan Dongting Pharmaceutical Basic Information, Quetiapine Manufacturing Base, Sales Area and Its Competitors
Table 158. Hunan Dongting Pharmaceutical Quetiapine Product Offered
Table 159. Hunan Dongting Pharmaceutical Quetiapine Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 160. Hunan Dongting Pharmaceutical Main Business
Table 161. Hunan Dongting Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Quetiapine
Figure 2. Quetiapine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Quetiapine Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Quetiapine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Quetiapine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Immediate Release Tablets
Figure 10. Product Picture of Extended Release Tablets
Figure 11. Global Quetiapine Sales Market Share by Type in 2021
Figure 12. Global Quetiapine Revenue Market Share by Type (2017-2022)
Figure 13. Quetiapine Consumed in Adult
Figure 14. Global Quetiapine Market: Adult (2017-2022) & (K Pcs)
Figure 15. Quetiapine Consumed in Old Man
Figure 16. Global Quetiapine Market: Old Man (2017-2022) & (K Pcs)
Figure 17. Quetiapine Consumed in Children And Adolescents
Figure 18. Global Quetiapine Market: Children And Adolescents (2017-2022) & (K Pcs)
Figure 19. Global Quetiapine Sales Market Share by Application (2017-2022)
Figure 20. Global Quetiapine Revenue Market Share by Application in 2021
Figure 21. Quetiapine Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Quetiapine Revenue Market Share by Company in 2021
Figure 23. Global Quetiapine Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Quetiapine Revenue Market Share by Geographic Region in 2021
Figure 25. Global Quetiapine Sales Market Share by Region (2017-2022)
Figure 26. Global Quetiapine Revenue Market Share by Country/Region in 2021
Figure 27. Americas Quetiapine Sales 2017-2022 (K Pcs)
Figure 28. Americas Quetiapine Revenue 2017-2022 ($ Millions)
Figure 29. APAC Quetiapine Sales 2017-2022 (K Pcs)
Figure 30. APAC Quetiapine Revenue 2017-2022 ($ Millions)
Figure 31. Europe Quetiapine Sales 2017-2022 (K Pcs)
Figure 32. Europe Quetiapine Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Quetiapine Sales 2017-2022 (K Pcs)
Figure 34. Middle East & Africa Quetiapine Revenue 2017-2022 ($ Millions)
Figure 35. Americas Quetiapine Sales Market Share by Country in 2021
Figure 36. Americas Quetiapine Revenue Market Share by Country in 2021
Figure 37. United States Quetiapine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Quetiapine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Quetiapine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Quetiapine Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Quetiapine Sales Market Share by Region in 2021
Figure 42. APAC Quetiapine Revenue Market Share by Regions in 2021
Figure 43. China Quetiapine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Quetiapine Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Quetiapine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Quetiapine Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Quetiapine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Quetiapine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Quetiapine Sales Market Share by Country in 2021
Figure 50. Europe Quetiapine Revenue Market Share by Country in 2021
Figure 51. Germany Quetiapine Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Quetiapine Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Quetiapine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Quetiapine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Quetiapine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Quetiapine Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Quetiapine Revenue Market Share by Country in 2021
Figure 58. Egypt Quetiapine Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Quetiapine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Quetiapine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Quetiapine Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Quetiapine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Quetiapine in 2021
Figure 64. Manufacturing Process Analysis of Quetiapine
Figure 65. Industry Chain Structure of Quetiapine
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs